Skip to Main Content

Paper Details

Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with Vandetanib.
Clin Cancer Res
19
2018
Advanced, Children, Hereditary Medullary Thyroid Carcinoma, MTC, Met918Thr, RET, RET p.Met918Thr, RET p.Met918Thr mutation, Vandetanib, children, copy number, genome, hereditary MTC, medullary thyroid carcinoma, p, p.Met918Thr, patient, patients, tumor, vandetanib
Author NameAffiliation
Yuelin J ZhuCenter for Cancer Research, National Cancer Institute
Yuelin J ZhuCenter for Cancer Research, National Cancer Institute
Seth M SteinbergCenter for Cancer Research, National Cancer Institute
Seth M SteinbergCenter for Cancer Research, National Cancer Institute
Elizabeth FoxChildren's Hospital of Philadelphia
Maria J MerinoCenter for Cancer Research, National Cancer Institute
Maria J MerinoCenter for Cancer Research, National Cancer Institute
Paul S MeltzerCenter for Cancer Research, National Cancer Institute
Paul S MeltzerCenter for Cancer Research, National Cancer Institute
Jack F ShernCenter for Cancer Research, National Cancer Institute
Brigitte C WidemannCenter for Cancer Research, National Cancer Institute
  • 1 - 11

Datasets

Release 1.2